IFG Advisory’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
IFG Advisory's MRNA Position: Q2 2026 in Review
IFG Advisory opened a new position in Moderna (MRNA) in Q2 2026: 3,925 shares worth $275K. The stake represents 0.01% of the portfolio and ranks #773 among its holdings. This is a return to the name: IFG Advisory previously reported a position in MRNA as recently as Q4 2025.
IFG Advisory first reported a position in MRNA in Q4 2025 and has held it in 2 quarters since. The position peaked at $361K in Q4 2025. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- IFG Advisory held 3,925 shares of Moderna worth $275K as of Q2 2026.
- Moderna was a new IFG Advisory position in Q2 2026.
- Moderna made up 0.01% of IFG Advisory's portfolio in Q2 2026, its #773 holding.
- IFG Advisory first reported a position in Moderna in Q4 2025 and has held it in 2 quarters since.
- IFG Advisory's Moderna position peaked at $361K in Q4 2025.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.